Litigation Details for AbbVie Inc. v. Cipla Limited (D. Del. 2017)
✉ Email this page to a colleague
AbbVie Inc. v. Cipla Limited (D. Del. 2017)
| Docket | ⤷ Sign Up | Date Filed | 2017-11-10 |
| Court | District Court, D. Delaware | Date Terminated | 2018-04-05 |
| Cause | 35:271 Patent Infringement | Assigned To | Richard Gibson Andrews |
| Jury Demand | None | Referred To | |
| Patents | 7,148,359; 7,364,752; 8,025,899; 8,268,349; 8,309,613; 8,377,952; 8,399,015; 8,470,347; 8,691,878 | ||
| Link to Docket | External link to docket | ||
Details for AbbVie Inc. v. Cipla Limited (D. Del. 2017)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2017-11-09 | 1 | United States Patent No. 7,148,359 C1 (together “the ’359 Patent”); (2) United States Patent Number 7,364,752… civil action for patent infringement of: (1) United States Patent Number 7,148,359 B2 as amended by …1272nd), which amended the ’359 Patent as United States Patent No. 7,148,359 C1. AbbVie is the owner by … & 100mg/ 25mg With Respect to U.S. Patent Nos. 7,148,359; 6,364,752; 8,025,899; 8,268,349; 8,309,613…United States Patent No. 7,364,752 C1 (together “the ’752 Patent”); (3) United States Patent Number 8,025,899 | External link to document | |
| 2018-04-06 | 12 | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,148,359; 7,364,752; 8,025,899…2017 5 April 2018 1:17-cv-01631 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document | |
| 2017-11-09 | 4 | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,148,359; 7,364,752; 8,025,899…2017 5 April 2018 1:17-cv-01631 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
